Contact
The UPV is a mixed technological platform of the Autonomous University of Barcelona and the Vall d'Hebron Research Institute specializing in the production, purification and characterization of viral vectors for gene therapy for public and private institutions.
Universitat Autònoma de Barcelona (UAB)
Gene Therapy; viral vectors; biomedicine; biotechnology; adeno-associated vectors; adenoviral vectors; ATMP; Advanced Therapies; viruses; biosafety
Want more information about TECNIO Technology Developers?
Technological capabilities
With 30 years of experience in adenoviral and AAV vectors, we have the ability to generate a wide range of viral vectors, a proven track record in both preclinical and clinical studies, as well as active lines of research and development for optimizing procedures. As a result, our center is one of only 6 gene therapy groups participating in the Network of Excellence in Advanced Therapies (RICORS-TERAV) funded by the Carlos III Health Institute (ISCIII).
The technological products and services offered by the UPV are:
- Design, production, purification and characterization of viral vectors (adenoviruses and adeno-associated viruses) customized specifically for the requesting researcher
- Distribution of aliquots of vectors with marker genes, for preclinical and proof-of-concept experiments
- Amplification and characterization of previously generated vectors
- Sterility and quality controls
- Advice on biosafety and biodistribution of viral vectors
- Advice on the selection and design of viral vectors
- Independent characterization of viral vectors produced in other laboratories or production units
TOPTechnological fields
Biotechnology; Design new drugs / vaccines
Relevant equipment
The UPV has a division NSB2/NSB3 of Biosecurity notified by the National Biosecurity Commission (A/ES/14/I-29).
UPV - UAB - TechLab location
